Strides Pharma up 2% on zero observations to Bangalore facility from USFDA

The facility in Bangalore manufacturers tablets, capsules, liquids, creams ointments, sachets.


Share price of Strides Pharma Science rose 2.4 percent in the early trade on Wednesday as company received zero observations from USFDA.

The company has received the establishment inspection report (EIR) for its Bangalore facility, there by confirming the successful closure of the inspections.

The company’s formulations facility (KRSG Gardens) in Bangalore inspected by the USFDA in August 2018 and November 2018 had concluded with Zero 483 observations.

TWO DAYS FREE TRIALS AND BEST SERVICE PACKAGES  FOR DEALING IN STOCK MARKET. CLICK HERE >> Call Put Option Tips OR ONE MISSED CALL ON @9644405056

No comments:

Post a Comment

Designed with by Way2themes | Distributed by Blogspot Themes